ποΈ Verified NIH Record β’ Updated 2024-11-12
Evaluation of the Safety and Efficacy of TLD in Patients with COPD (NCT03639051)
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvairaβ’ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
π΅ Active, Not Recruiting Observational / Diagnostic βοΈ Medical Device Protocol Sponsor: Nuvaira, Inc.
π©Ί Plain-English Summary (8th-Grade Level)
The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System (Nuvaira System) in the treatment of COPD.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham (UAB) Lung Health Center β Birmingham, Alabama
Age range: 40 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (33 Sites)
Showing the first 25 of 33 sites.
- University of Alabama at Birmingham (UAB) Lung Health Center β Birmingham, Alabama
- HonorHealth β Phoenix, Arizona
- UC Davis β Sacramento, California
- Harbor UCLA β Torrance, California
- Ascension St. Vincent's β Jacksonville, Florida
- University of Chicago β Chicago, Illinois
- Suburban Lung Associates β Elk Grove Village, Illinois
- University of Louisville β Louisville, Kentucky
- Lahey Hospital & Medical Center β Burlington, Massachusetts
- University of Michigan β Ann Arbor, Michigan
- Spectrum Health Medical Group β Grand Rapids, Michigan
- Washington University β St Louis, Missouri
- Duke University β Durham, North Carolina
- First Health of the Carolinas β Pinehurst, North Carolina
- Ohio State University Wexner Medical Center β Columbus, Ohio
- Temple Lung Center β Philadelphia, Pennsylvania
- University of Pittsburgh Medical Center (UPMC) β Pittsburgh, Pennsylvania
- Medical University of South Carolina (MUSC) β Charleston, South Carolina
- St. Davids HealthCare β Georgetown, Texas
- Houston Methodist Hospital β Houston, Texas
- Krankenhaus Nord - Klinik Floridsdorf β Vienna,
- CHU de Grenoble β Grenoble, Cedex 9
- Hopital Larrey β Toulouse, Cedex 9
- Hopital de la Cavale Blanche β Brest,
- Arnaud de Villeneuve Hospital β Montpellier,
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in COPD
- Aiding COPD and CHF Ultrasound-guided Management Through ENhanced Point Of Care UltraSound β Calgary,
- Impairments That Affect Correct Inhaler Use in COPD β Birmingham, Alabama
- The Development of an Integrated Physical Activity and Mental Health Intervention for Veterans With COPD, Emotion Distress, and Low Physical Activity β Boston, Massachusetts
- A Study to Evaluate Solrikitug in Participants With COPD (ZION) β Birmingham, Alabama
- RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD β Calgary, Alberta
Explore by condition: All COPD clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.